Salts of Therapeutic Agents: Chemical, Physicochemical, and Biological Considerations
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The physicochemical and biological properties of active pharmaceutical ingredients (APIs) are greatly affected by their salt forms. The choice of a particular salt formulation is based on numerous factors such as API chemistry, intended dosage form, pharmacokinetics, and pharmacodynamics. The appropriate salt can improve the overall therapeutic and pharmaceutical effects of an API. However, the incorrect salt form can have the opposite effect, and can be quite detrimental for overall drug development. This review summarizes several criteria for choosing the appropriate salt forms, along with the effects of salt forms on the pharmaceutical properties of APIs. In addition to a comprehensive review of the selection criteria, this review also gives a brief historic perspective of the salt selection processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Approximately 50% of marketed drugs are administered as ionized salts (e.g., combined with sodium, chloride, potassium, magnesium, calcium), which allow for manipulation of pharmacokinetics, improved bioavailability (e.g., enhanced disassociation in the gastrointestinal tract), greater shelf-life stability, and easier manufacturing [11].”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ritonavir: An Extraordinary Example of Conformational Polymorphism
Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W., & Morris, J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011052932607 · Cited by 1,071
Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development
Chemburkar, S. R., Bauer, J., Deming, K., Spiwek, H., Patel, K., Morris, J., Henry, R., Spanton, S., Dziki, W., Porter, W., et al. (2000) · Organic Process Research & Development · doi:10.1021/op000023y · Cited by 687
Acid–base crystalline complexes and the pKa rule
Cruz-Cabeza, A. J. (2012) · CrystEngComm · doi:10.1039/c2ce26055g · Cited by 673
Drug polymorphism and dosage form design: a practical perspective
Singhal, D. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.008 · Cited by 596
Permeation enhancer strategies in transdermal drug delivery
Marwah, H., Garg, T., Goyal, A. K., & Rath, G. (2016) · Drug Delivery · doi:10.3109/10717544.2014.935532 · Cited by 529
Hydrogen bond-directed cocrystallization and molecular recognition properties of diarylureas
Etter, M. C., Urbanczyk-Lipkowska, Z., Zia-Ebrahimi, M., & Panunto, T. W. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00179a028 · Cited by 507
Khankari, R. K., & Grant, D. J. W. (1995) · Thermochimica Acta · doi:10.1016/0040-6031(94)01952-d · Cited by 485
Berge, S. M., Bighley, L. D., & Monkhouse, D. C. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660104 · Cited by 479
Disappearing Polymorphs Revisited
Bučar, D., Lancaster, R. W., & Bernstein, J. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410356 · Cited by 395
Salt selection for basic drugs
Gould, P. L. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90055-4 · Cited by 314
Cited by
Bays, H. E., Fitch, A., Christensen, S., Burridge, K., & Tondt, J. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100018 · Cited by 68
Metadata
- Authors
- Gupta, D., Bhatia, D., Dave, V., Sutariya, V., & Varghese Gupta, S.
- Affiliations
- Lake Erie College of Osteopathic Medicine (US)
- Shenandoah University (US)
- St. John Fisher University (US)
- University of South Florida (US)
- Department of Pharmaceutical Sciences, USF College of Pharmacy, Tampa, FL 33612, USA
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-07-14
- Volume
- 23
- Issue
- 7
- Pages
- 1719
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6100526
- OpenAlex
- W2800384110
- Cited by
- 267
- References
- 53
- Citations by year
- 2026: 30 · 2025: 57 · 2024: 49 · 2023: 44 · 2022: 31 · 2021: 21 · 2020: 25 · 2019: 8
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons - University of South Florida (University of South Florida) (submittedVersion, cc-by)
- Fisher Digital Publications (St. John Fisher College) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of South Florida
- Topics
- Physical Sciences › Materials Science › Materials Chemistry › Crystallization and Solubility Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- drug salts, active pharmaceutical ingredients, salt selection, physicochemical properties, pharmacokinetics, pharmacodynamics, pharmaceutical dosage forms, drug development
- MeSH terms
- Animals, Drug Administration Routes, Pharmaceutical Preparations, Humans, Salts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



